Two tech giants will set up AI-powered Athinia platform
Merck announced on Dec. 15 that the German corporation had joined hands with Palantir Technologies to build an AI-powered data analytics platform for the semiconductor industry.
Merck said that the new-concept platform, dubbed Athinia, will take advantage of AI and big data to help solve such critical challenges as chip shortages and improve quality.
Over the past few years, many industries have suffered from the supply bottleneck of semiconductors, as amply demonstrated by the automotive business.
Merck’s chief science and technology officer Laura Matz will spearhead the partnership as CEO of Athinia.
“The semiconductor industry is facing unprecedented disruption. This has created a critical need for a secure data collaboration platform that can provide the transparency and data intelligence companies need to solve challenges such as chip shortages and supply chain issues,” said Kai Beckmann, a member of the Executive Board of Merck and CEO Electronics.
“Partnering with Palantir, we’ve combined our collective expertise in materials science, data analytics, and security to increase our customers’ efficiencies and time to innovation.”
Palantir COO Shyam Sankar also expressed the firm’s hype on the bilateral collaboration. Plantir is a top builder of operating systems for modern enterprises.
“We are excited to partner with market leaders in this space to create an ecosystem that will enable semiconductor companies and their suppliers to collaborate to make better decisions, combatting simultaneous demand and supply shocks,” Sankar said.
“Athinia will help companies across the value chain bring new products to market faster and accelerate their product differentiation and growth.”
Athinia strives to enable advanced data analytics based on Palantir’s unique experience in building inter-organization ecosystems, according to Merck.
The platform also vies to help fabs manage faster innovation in manufacturing processes in a single, secure platform that will support improved incoming material quality and increase supplier engagement.
In fact, this is not the first time for the two outfits to join forces.
Back in 2017, they started collaborating through a partnership called “Syntropy.” They have tried to unleash the power of biomedical data and accelerate research.
Merck said that Syntropy’s aim is to provide researchers with intuitive analytics techniques to enable them to aggregate, analyze, and then also share data from disparate sources.